Difficulty: Medium
Average Score: 70%
Practice
Which one of the following enzymes is not unique to parasites?
Correct answer
B
Rationale
In the context of chemotherapy drugs and their mechanisms of action, understanding the unique enzymes found in parasites is crucial for developing targeted treatments. In this question, the correct answer is B) Hypoxanthine-guanine phosphoribosyltransferase.
Hypoxanthine-guanine phosphoribosyltransferase is not unique to parasites. This enzyme is also found in humans and plays a role in the salvage pathway of purine nucleotide synthesis. Therefore, it is not a suitable target for developing drugs that specifically target parasite enzymes without affecting human cells.
Option A) Dihydropteridine pyrophosphokinase is unique to parasites and is involved in the folate synthesis pathway, making it a potential target for antiparasitic drugs.
Option C) Lanosterol demethylase is also unique to parasites and is involved in the synthesis of ergosterol, a crucial component of the parasite cell membrane. Inhibiting this enzyme can disrupt the parasite's membrane structure and function.
Option D) Purine nucleoside phosphotransferase is unique to parasites and plays a role in the purine salvage pathway, making it a potential target for antiparasitic drugs.
Understanding the unique enzymes in parasites not only aids in developing more effective chemotherapy drugs but also highlights the importance of drug specificity to minimize side effects on human cells. This knowledge is essential for pharmacologists, researchers, and healthcare professionals involved in combating parasitic infections.
Hypoxanthine-guanine phosphoribosyltransferase is not unique to parasites. This enzyme is also found in humans and plays a role in the salvage pathway of purine nucleotide synthesis. Therefore, it is not a suitable target for developing drugs that specifically target parasite enzymes without affecting human cells.
Option A) Dihydropteridine pyrophosphokinase is unique to parasites and is involved in the folate synthesis pathway, making it a potential target for antiparasitic drugs.
Option C) Lanosterol demethylase is also unique to parasites and is involved in the synthesis of ergosterol, a crucial component of the parasite cell membrane. Inhibiting this enzyme can disrupt the parasite's membrane structure and function.
Option D) Purine nucleoside phosphotransferase is unique to parasites and plays a role in the purine salvage pathway, making it a potential target for antiparasitic drugs.
Understanding the unique enzymes in parasites not only aids in developing more effective chemotherapy drugs but also highlights the importance of drug specificity to minimize side effects on human cells. This knowledge is essential for pharmacologists, researchers, and healthcare professionals involved in combating parasitic infections.